These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38386790)

  • 41. [Smoking Cessation after Bladder Cancer Diagnosis].
    Mota P; Sousa PM; Botelho F; Carvalho-Dias E; Cordeiro A; Torres JP; Morais N; Anacleto S; Lima E
    Acta Med Port; 2018 Feb; 31(2):101-108. PubMed ID: 29596769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012.
    Kim EY; Shim YS; Kim YS; Lee SP; Ko KD; Choi WJ
    PLoS One; 2019; 14(10):e0224224. PubMed ID: 31639166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of long-term smoking cessation: results from the global adult tobacco survey in Poland (2009-2010).
    Kaleta D; Korytkowski P; Makowiec-Dąbrowska T; Usidame B; Bąk-Romaniszyn L; Fronczak A
    BMC Public Health; 2012 Nov; 12():1020. PubMed ID: 23173904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.
    Chen LS; Baker T; Hung RJ; Horton A; Culverhouse R; Hartz S; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Rosenberger A; Aben KK; Andrew AS; Chang SC; Saum KU; Dienemann H; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden EH; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Brüske I; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare MD; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Amos CI; Bierut LJ
    EBioMedicine; 2016 Sep; 11():219-226. PubMed ID: 27543155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamics of smoking cessation and health-related quality of life among Canadians.
    Shields M; Garner RE; Wilkins K
    Health Rep; 2013 Feb; 24(2):3-11. PubMed ID: 24257905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.
    Hektoen HH; Robsahm TE; Andreassen BK; Stenehjem JS; Axcrona K; Mondul A; Gislefoss RE
    Cancer Med; 2020 Jun; 9(12):4420-4432. PubMed ID: 32319230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.
    Tindle HA; Stevenson Duncan M; Greevy RA; Vasan RS; Kundu S; Massion PP; Freiberg MS
    J Natl Cancer Inst; 2018 Nov; 110(11):1201-1207. PubMed ID: 29788259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking.
    Reid A; de Klerk NH; Ambrosini GL; Berry G; Musk AW
    Occup Environ Med; 2006 Aug; 63(8):509-12. PubMed ID: 16849527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indicators of cigarette smoking dependence and relapse in former smokers who vape compared with those who do not: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey.
    McNeill A; Driezen P; Hitchman SC; Cummings KM; Fong GT; Borland R
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):49-60. PubMed ID: 31225672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quitting smoking among adults--United States, 2001-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1513-9. PubMed ID: 22071589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing risk in smokers.
    Westmaas JL; Brandon TH
    Curr Opin Pulm Med; 2004 Jul; 10(4):284-8. PubMed ID: 15220753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
    Grotenhuis AJ; Ebben CW; Aben KK; Witjes JA; Vrieling A; Vermeulen SH; Kiemeney LA
    Urol Oncol; 2015 Feb; 33(2):65.e9-17. PubMed ID: 25023787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ten-year weight gain in smokers who quit, smokers who continued smoking and never smokers in the United States, NHANES 2003-2012.
    Veldheer S; Yingst J; Zhu J; Foulds J
    Int J Obes (Lond); 2015 Dec; 39(12):1727-32. PubMed ID: 26155918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.
    Samanic C; Kogevinas M; Dosemeci M; Malats N; Real FX; Garcia-Closas M; Serra C; Carrato A; García-Closas R; Sala M; Lloreta J; Tardón A; Rothman N; Silverman DT
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1348-54. PubMed ID: 16835335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pattern of medical charges after quitting smoking among those with and without arthritis, allergies, or back pain.
    Musich S; Faruzzi SD; Lu C; McDonald T; Hirschland D; Edington DW
    Am J Health Promot; 2003; 18(2):133-42. PubMed ID: 14621408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Li HM; Azhati B; Rexiati M; Wang WG; Li XD; Liu Q; Wang YJ
    Int Urol Nephrol; 2017 Jan; 49(1):69-76. PubMed ID: 27766490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of smoking cessation on multiple sclerosis disease progression.
    Rodgers J; Friede T; Vonberg FW; Constantinescu CS; Coles A; Chataway J; Duddy M; Emsley H; Ford H; Fisniku L; Galea I; Harrower T; Hobart J; Huseyin H; Kipps CM; Marta M; McDonnell GV; McLean B; Pearson OR; Rog D; Schmierer K; Sharrack B; Straukiene A; Wilson HC; Ford DV; Middleton RM; Nicholas R
    Brain; 2022 May; 145(4):1368-1378. PubMed ID: 34623418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Smoking and Smoking Cessation With Overall and Cause-Specific Mortality.
    Zhu D; Zhao G; Wang X
    Am J Prev Med; 2021 Apr; 60(4):504-512. PubMed ID: 33745522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reasons to quit and barriers to quitting smoking in US young adults.
    Villanti AC; Bover Manderski MT; Gundersen DA; Steinberg MB; Delnevo CD
    Fam Pract; 2016 Apr; 33(2):133-9. PubMed ID: 26733658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States.
    Inoue-Choi M; Christensen CH; Rostron BL; Cosgrove CM; Reyes-Guzman C; Apelberg B; Freedman ND
    JAMA Netw Open; 2020 Jun; 3(6):e206436. PubMed ID: 32492162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.